Loading...
Loading...
Of the 4 tracked institutions holding IHF, 2 have a 3-year clone track record — 2 of them beat the S&P. Average holder's clone alpha: +9.3pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 4 tracked institutional investors we monitor, IHF (ISHARES TR) is held with a combined value of $3.70M across 88,513 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $1.33M. 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$3.70M
Total Shares Held
88,513
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $1.33M | 0.00% | +19.8% |
| 2 | Point72 Asset Management, L.P. | $1.22M | 0.00% | +12.1% |
| 3 | FMR LLC | $990.91K | 0.00% | +23.9% |
| 4 | BlackRock, Inc. | $169.03K | 0.00% | -2.1% |
| Member | Type | Date |
|---|---|---|
| Markwayne Mullin | Sell | Sep 24, 2025 |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of IHF with a position worth $1.33M, representing 0.00% of their portfolio. In total, 4 institutional investors hold IHF with a combined value of $3.70M.
Institutional investors hold $3.70M worth of IHF stock across 4 positions. The largest institutional holder is CITADEL ADVISORS LLC with $1.33M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For IHF, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their IHF positions.
Last Close
$56.78
2026-07-27
YTD
+17.8%
96% of 52-week range